Organism: Homo sapiens
Gene: 38634_at
Selected probe(set): 203423_at
Platform: Affymetrix Human Genome U133 Plus 2.0 Array

Expression of 38634_at (203423_at) across 6674 perturbations tested by GENEVESTIGATOR:

Relative Expression (log2-ratio):5.948518
Number of Samples:2 / 2

Experimental	expO ovary cancer study 1 (granulosa cell tumor, malignant; metastatic)
	Metastatic tumor tissue samples obtained from patients with primary granulosa cell tumor of the ovary.
Control	expO ovary cancer study 1 (dysgerminoma; metastatic)
	Metastatic tumor tissue samples obtained from patients with primary dysgerminoma of the ovary.

Relative Expression (log2-ratio):-5.8924227
Number of Samples:2 / 3

Experimental	glioma study 16 (LN-18)
	Human glioma cell line LN018 was cultured in DMEM supplemented with 10% FCS (fetal calf serum) and antibiotics at 37C and 5% CO2.
Control	normal astrocyte sample
	Normal brain astrocytes. Clonetics normal human astrocytes (NHA) from Cambrex (primary-derived cultures) and cultured according to the manufacturer's recommendations.

Relative Expression (log2-ratio):-5.2955904
Number of Samples:2 / 3

Experimental	glioma study 16 (BS-149)
	Human glioma cell line BS149 was cultured in DMEM supplemented with 10% FCS (fetal calf serum) and antibiotics at 37°C and 5% CO2.
Control	normal astrocyte sample
	Normal brain astrocytes. Clonetics normal human astrocytes (NHA) from Cambrex (primary-derived cultures) and cultured according to the manufacturer's recommendations.

Relative Expression (log2-ratio):-5.2943745
Number of Samples:2 / 3

Experimental	glioma study 16 (LN-215)
	Human glioma cell line LN215 was cultured in DMEM supplemented with 10% FCS (fetal calf serum) and antibiotics at 37°C and 5% CO2.
Control	normal astrocyte sample
	Normal brain astrocytes. Clonetics normal human astrocytes (NHA) from Cambrex (primary-derived cultures) and cultured according to the manufacturer's recommendations.

Relative Expression (log2-ratio):5.045347
Number of Samples:2 / 4

Experimental	expO ovary cancer study 1 (granulosa cell tumor, malignant; metastatic)
	Metastatic tumor tissue samples obtained from patients with primary granulosa cell tumor of the ovary.
Control	expO ovary cancer study 1 (clear cell adenocarcinoma, NOS; metastatic)
	Metastatic tumor tissue samples obtained from patients with primary clear cell adenocarcinoma (NOS) of the ovary.

Relative Expression (log2-ratio):-4.806572
Number of Samples:3 / 6

Experimental	pancreatic cancer study 3 (ipmn)
	Intraductal papillary mucinous neoplasm from patients with pancreatic cancer.
Control	normal pancreas tissue
	Normal human pancreatic tissue.

Relative Expression (log2-ratio):-4.7506447
Number of Samples:6 / 6

Experimental	pancreatic cancer study 3 (ipma)
	Intraductal papillary mucinous adenoma from patients with pancreatic cancer.
Control	normal pancreas tissue
	Normal human pancreatic tissue.

Relative Expression (log2-ratio):-4.569294
Number of Samples:6 / 6

Experimental	pancreatic cancer study 3 (ipmc)
	Intraductal papillary mucinous carcinoma from patients with pancreatic cancer.
Control	normal pancreas tissue
	Normal human pancreatic tissue.

Relative Expression (log2-ratio):-4.3188734
Number of Samples:4 / 2

Experimental	oxyphilic adenoma study 1
	Tumor tissue samples from the kidney of patients with oxyphilic adenoma (renal oncocytoma).
Control	normal kidney tissue (fetal)
	Normal fetal kidney tissue samples.

Relative Expression (log2-ratio):4.277481
Number of Samples:2 / 6

Experimental	expO breast cancer study 1 (papillary carcinoma, NOS; primary)
	Primary tumor tissue samples obtained from the breast of patients with papillary carcinoma (NOS).
Control	expO breast cancer study 1 (mucocarcinoid tumor, malignant; primary)
	Primary tumor tissue samples obtained from the breast of patients with malignant mucocarcinoid tumor.